Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

InDex Pharmaceuticals’ in-depth analysis of the CONDUCT study confirms the successful top line results and supports the strategy going forward

February 19, 2020 – InDex Pharmaceuticals Holding AB (publ) today announced the conclusions from in-depth analysis of the complete data set from the phase IIb dose optimisation study CONDUCT, evaluating the first-in-class TLR9 agonist cobitolimod for the treatment of moderate to severe ulcerative colitis. The analysis confirms that the highest dose tested, which met the primary endpoint of the study, demonstrates an outstanding combination of efficacy and safety.In-depth analysis of the complete data set has now been concluded and hence the Clinical Study Report can be finalised. As

SSM adopts new financial targets

SSM Holding AB (publ), Sweden’s leading developer of smart, affordable homes, has adopted new financial targets based on the company’s business plan for 2020–2024. The new targets and levels reflect the company’s strategic focus on developing increased share of rental projects.After having adopted a new five-year business plan for the years 2020 to 2024, SSM’s Board of Directors has resolved on new long-term financial targets for the company. The previous interest coverage ratio of at least 2x has been removed as a target at the same time as the current financial targets for operating

DNB Markets – Isofol Medical: Fully focused on AGENT

Q4’s operating loss was higher than expected, mainly due to continued higher R&D spending as well as costs related to the change of CEO. The 005-study has been concluded and the company’s full attention should now be on bringing arfolitixorin to market. We estimate continued high R&D spending going forward as more sites are expected to be opened. We have tweaked our estimated fair value to SEK14–42 (SEK18–49).Isofol reported a Q4 operating loss of cSEK55m. The reported loss was above our estimate of cSEK38m due to increased spending on R&D and higher personnel costs. The increase in

Hoist Finance issues EUR 40 million Additional Tier 1 capital

Hoist Finance AB (publ) (Baa3/stable), ("Hoist Finance"), today announces that it has issued Additional Tier 1 capital to further optimise its capital structure. The instrument is perpetual with a non-call period of 5.00 years with a fixed coupon of 7.750 per cent. The instrument will be listed on the Global Exchange Market regulated by Euronext Dublin. “We are very pleased with the terms for the new issue, which were underpinned by demand substantially exceeding the issued amount” says Mathias Zetterqvist, Head of Treasury. Citi and Nordea acted as joint bookrunners on the

Annual general meeting of Handelsbanken’s shareholders, 25 March 2020

Svenska Handelsbanken AB (publ) invites its shareholders to attend the annual general meeting at 9.30 a.m. CET on Wednesday, 25 March 2020 at the Grand Hôtel’s Winter Garden, Stallgatan 4, Stockholm.The agenda includes the Board’s proposal for a dividend of SEK 5.50 per share.The nomination committee proposes re-election of the following members of the Board: Mr Jon Fredrik Baksaas, Mr Hans Biörck, Mr Pär Boman, Ms Kerstin Hessius, Ms Lise Kaae, Mr Fredrik Lundberg, and Ms Carina Åkerström. The nomination committee proposes that the meeting elect Mr Ulf Riese and Ms Arja Taaveniku as

First patient enrolled in pivotal Phase III clinical study SPARKLE with lead candidate Mangoral

Ascelia Pharma AB (publ) (ticker: ACE) today announced that the first patient has been enrolled in the company’s global pivotal Phase III clinical study SPARKLE with Mangoral in patients with severely reduced renal function and with known or suspected liver lesions.“It is an important event for patients seeking a safe agent to detect liver lesions that this pivotal Phase III study is now enrolling study subjects. We see the interest from premier hospitals and expert doctors to participate as a testimony to the unique potential offered by Mangoral and the large unmet medical need for these

Midsummer’s year-end report 2019

Solar energy technology company  Midsummer  today announced its annual report for 2019. Net revenues were SEK 184.5m with an operating loss of SEK 23.1m. In Q4, the company has opened a new research and development facility with a new production line for integrated solar roofs, received a new order for two DUO systems from a European customer and done its first installation of the solar panel Wave.Midsummer announces net revenues of SEK 28.8m for the 4[th] quarter 2019. Net revenues for the whole year 2019 were SEK 184.5m. The group’s operating result for the last

Swedbank Mortgage’s Annual Report 2019 published

Swedbank Mortgage’s Annual Report for 2019 has been published at www.swedbank.com/investor-relations/reports-and-presentation/subsidiary-reports/swedbank.mortgage.html Swedbank Mortgage AB (in Swedish: Swedbank Hypotek) is a wholly owned subsidiary to Swedbank AB (publ). Mortgages are distributed through Swedbank’s and the Swedish savings banks branches as well as digital channels.   Swedbank Mortgage AB (publ) is required to disclose this information pursuant to the Swedish Securities Markets Act (2007:528). This information was sent to be published on 19 February, 2020 at 18:25

Welcome to Swedbank’s Annual General Meeting 2020

The shareholders in Swedbank AB are hereby given notice to the Annual General Meeting at Cirkus, Djurgårdsslätten 43-45, Stockholm, on Thursday 26 March, 2020 at 11:00 am (CET).Shareholders are welcome from 9:15 am (CET). Before the Meeting, Swedbank management will be available in the lobby. Light refreshments will be provided in connection hereto. As a service to non-Swedish speaking shareholders, the meeting will be simultaneously interpreted into English. Notification etcShareholders who wish to attend the Annual General Meeting must be recorded in the share register maintained

Swedbank’s Annual Report 2019 published

Swedbank’s Annual and Sustainability Report for 2019 has been published at swedbank.com/ir  together with the bank’s Risk Management and Capital Adequacy Report 2019. Swedbank’s sustainability work is a central part of the bank’s operations and the sustainability report is thus an integral part of the Annual Report. Contact:Gregori Karamouzis, Head of Investor Relations, phone: + 46 72 740 63 38Fredrik Nilzén, Head of Group Sustainability, phone: +46 76 773 19 26Unni Jerndal, Group Press Officer, phone: +46 73 092 11 80 Swedbank AB (

Resurs Bank issues SEK 700 million of senior unsecured bonds

Resurs Bank AB has issued SEK 700 million of senior unsecured bonds in the Nordic market. The 3 year bonds (with maturity February 2023) will be listed on Nasdaq Stockholm. The offer attracted very strong demand and resulted in an oversubscribed orderbook. The bonds are issued under Resurs Bank’s MTN programme with a total frame of SEK 8 billion and pays a coupon of 3m Stibor + 1.28%. Nordea and SEB acted as joint book runners in the transaction.     For additional information:Christina Kassberg, CFO & Head of IR, christina.kassberg@resurs.se +46 42 38 20 00Christina

Resurs Bank issues SEK 700 million of senior unsecured bonds

Resurs Bank AB, a wholly owned subsidiary of Resurs Holding AB (Nasdaq Stockholm: RESURS), has issued SEK 700 million of senior unsecured bonds in the Nordic market. The 3 year bonds (with maturity February 2023) will be listed on Nasdaq Stockholm. The offer attracted very strong demand and resulted in an oversubscribed orderbook. The bonds are issued under Resurs Bank’s MTN programme with a total frame of SEK 8 billion and pays a coupon of 3m Stibor + 1.28%. Nordea and SEB acted as joint book runners in the transaction.     For additional information:Christina Kassberg,

Cantargia announces intention of a directed share issue

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA, THE "UNITED STATES"), AUSTRALIA, CANADA, HONG KONG, ISRAEL, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE.February 19, 2020 – Cantargia AB (publ) (“Cantargia” or the “Company”) (Nasdaq Stockholm: CANTA) hereby

Sivers IMA announces intention of directed share issue

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE. Sivers IMA Holding AB (”Sivers IMA” or the ”Company”) today announces its intention of a placement of up to 5,955,418 new shares (corresponding to approximately 4.5 percent of the

EAB GROUP PLC: ACQUISITION OF OWN SHARES 19.02.2020

EAB GROUP PLC NOTIFICATION 19.02.2020 at 18:30 EAB GROUP PLC: ACQUISITION OF OWN SHARES 19.02.2020   Date 19.02.2020  Exchange transaction Buy  Share class EAB  Amount 328  Average price/share 3.0200 EURHighest price/share 3.0200 EURLowest price/share 3.0200 EURTotal price 990.56 EUR      The shares held by EAB Group Plc on 19.02.2020:   EAB 12,860     On behalf of EAB Group Plc  Skandinaviska Enskilda Banken

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 19.02.2020

Fiskars Corporation NOTIFICATION 19.02.2020 at 18:30 EET/EEST FISKARS CORPORATION: ACQUISITION OF OWN SHARES 19.02.2020   Date 19.02.2020  Exchange transaction Buy  Share class FSKRS  Amount       1,000  Average price/share 12.2040 EURHighest price/share 12.2200 EURLowest price/share 12.1800 EURTotal price 12,204.00 EUR      The shares held by Fiskars Corporation on 19.02.2020:     FSKRS  420,677     On behalf of Fiskars

VALMET Oyj: ACQUISITION OF OWN SHARES 19.02.2020

Valmet Oyj NOTIFICATION 19.02.2020 at 18:30 VALMET Oyj: ACQUISITION OF OWN SHARES 19.02.2020 Date 19.02.2020Exchange transaction BuyShare class VALMTAmount 27,000Average price/share 24.0056 EURHighest price/share 24.0800 EURLowest price/share 23.9000 EURTotal price 648,151.20 EUR The shares held by Valmet Oyj on 19.02.2020: VALMT 459,596 On behalf of Valmet OyjSkandinaviska Enskilda Banken AB (Publ) Antti Salakka         Mikko Virtanen For more information, please contact:

#20-63 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

Let’s celebrate Beethoven and immerse ourselves in culture!

Although 2020 has only just started, it already looks like it’s going to be a year of inspirational culture! The FrankfurtRhineMain region  in Germany has an explosive menu of cultural and culinary highlights awaiting you this year – from UNIQUE gin, Benedictine wine, and special exhibitions all the way to Beethoven himself. It’s time to dive into a year of cultural surprises!Let’s celebrate Beethoven’s 250th anniversary! It’s the Beethoven Anniversary Year, a time to celebrate the genius! And what better way to do this than with music? The

Elos Medtech launches Elos Accurate[®] Hybrid Base™ in the U.S.

Elos Medtech is pleased to announce that the company has received FDA 510(k) clearance to market Elos Accurate[ ]Hybrid Base on the U.S. dental implant market. Elos Accurate[ ]Hybrid Base is a prosthetic product within digital dentistry and is used for single crowns and bridges on dental implants. The product is compatible with several implant platforms from leading dental implant companies and has so far only been sold on the European market. By the clearance of Elos Accurate Hybrid Base, we get a complete offer within our digital product portfolio in the U.S. The North American market

Profit warning: Avidly specifies its 2019 EBIT guidance

Profit warning: Avidly specifies its 2019 EBIT guidance Avidly Plc, inside information, 19 February 2020 at 17.15 Avidly specifies its 2019 EBIT guidance based on the preliminary unaudited annual accounts. Avidly’s previous  guidance was issued on 9 October 2019. Avidly estimates that its EBIT in 2019 will be approximately -2.4 million euros. Earlier Avidly estimated that its revenue for 2019 will be EUR 22 - 24 million and that EBIT for 2019 will be negative (EBIT in 2018: EUR 0.6 million). Avidly reiterates its revenue guidance for 2019. “Avidly’s investments in

Ponsse strengthens its position in the harvester head market

PONSSE launches new H9 harvester head at the Oregon Logging Conference in USA. The new harvester head strengthens Ponsse's strategy to be the leading manufacturer also for harvester heads. The new PONSSE H9 challenges other products in the same size class with its power and precision.- Listening to the needs of our customers, we developed a robust cutting head for tracked machines. The new PONSSE H9 harvester head is capable of processing, felling and multi-stemming even large trunks. Thanks to the felling feature, the new harvester head has a decent tilt function and the top saw option

The Swedish Sea Rescue Society (SSRS) order Two RescueRunner systems

We are happy to announce that the Swedish Sea Rescue Society (SSRS) strengthens their fleet with two more RescueRunner systems.It’s a donation by Båtkusten, Imatech Marin & Industri AB's Swedish Volvo Penta dealer network, that enables the order of two new RescueRunner systems. Båtkusten have during two years worked very hard to save and gather the funding for making this donation possible and it was therefore with great joy the check was handed over to SSRS at the Gothenburg Boat Show last month.  SSRS is the organization with the largest RescueRunner fleet in the world. Today SSRS

Outokumpu – Announcement regarding change in holdings

Outokumpu OyjStock exchange release    February 19, 2020 at 5.00 pm EETOutokumpu – Announcement regarding change in holdingsOutokumpu Oyj (business identity code: 0215254-2) has on February 19, 2020 received a notification based on Chapter 9, Section 5 of the Finnish Securities Market Act. Société Générale SA’s total holding in the shares and voting rights of Outokumpu has risen above 5% threshold and was 5.39% on February 17, 2020. Their earlier holding in the Outokumpu shares and voting rights was below minimum threshold.    Total direct and

There are no items matching the current filter
There are no more items matching the current filter
Back to top